C. Fretz

发表

Poor procedures and quality control among nonaffiliated blood centers in Burkina Faso: an argument for expanding the reach of the national blood transfusion center

E. Murphy, K. Nebie, S. Ouattara, 2011, Transfusion.

Hepatitis virus infections in heart transplant recipients.

L. Frangeul, C. Fretz, P. Opolon, 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Côte d'Ivoire.

B. Gessner, P. Chauvin, C. Fretz, 2008, Vaccine.

Liver dysfunction in allogeneic bone marrow transplantation recipients.

D. Valla, V. Leblond, J. Binet, 1996, Transplantation.

Posttransplantation cytotoxic immunoglobulin G is associated with a high rate of acute allograft dysfunctions in heart transplant recipients.

A. Pavie, P. Leprince, P. Nataf, 1999, American heart journal.

Transfusion‐associated or nosocomial hepatitis G virus infection in patients undergoing surgery

D. Valla, C. Bréchot, J. Huraux, 2008, Transfusion.

Post-transfusional anti-HCV-negative, non-A, non-B hepatitis. (I) a prospective clinical and epidemiological survey.

D. Valla, C. Blanc, C. Fretz, 1993, Journal of hepatology.

Post-transfusional anti-HCV-negative non-A non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses.

D. Valla, C. Bréchot, J. Huraux, 1993, Journal of hepatology.

Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival.

L. Stuyver, J. Huraux, C. Fretz, 2000, Gastroenterology.

Hepatitis C virus (HCV) genotype analysis in apparently healthy anti‐ HCV‐positive Parisian blood donors

L. Stuyver, G. Leroux-Roels, G. Maertens, 1996, Transfusion.

Evidence for high genetic diversity and long‐term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa

L. Stuyver, F. Fumoux, G. Maertens, 1998, Journal of medical virology.

Residual risk of HIV, HVB and HCV transmission by blood transfusion between 2002 and 2004 at the Abidjan National Blood Transfusion Center.

C. Fretz, S. Konaté, J. Hyda, 2006, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Infections à cytomégalovirus post-transfusionnelles : incidence et moyens de prévention

J. Emile, C. Fretz, G. Andreu, 1991 .

Impact of hepatitis B and C virus on kidney transplantation outcome

P Coriat, P. Coriat, C. Fretz, 1999, Hepatology.

HCV infection in a rural population of the Central African republic (CAR): Evidence for three additional subtypes of genotype 4

L. Stuyver, G. de Thé, C. Mathiot, 1995, Journal of medical virology.

Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis

C. Trépo, P. Hervé, Y. Matillon, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Regional differences in human retroviral infections HIV-1, HIV-2, and HTLV-I/II in rural Guinea (west Africa)

G. de Thé, A. Gessain, C. Fretz, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Evidence of HTLV-II infection in Guinea, West Africa.

G. de Thé, A. Gessain, C. Fretz, 1993, Journal of acquired immune deficiency syndromes.

Oral lichen planus and hepatitis C virus infection: a fortuitous association?

N. Dupin, O. Chosidow, C. Fretz, 1997, Archives of dermatology.

Screening Blood Donations for Hepatitis C in Central Africa

L. Bélec, C. Fretz, G. Grésenguet, 1999, Medical decision making : an international journal of the Society for Medical Decision Making.